
Do humour and laughter benefit your health?
enjoys humour
and likes a good laugh. We find humour relaxing, which reduces stress; therefore, most people tend to believe that humour is good for our general health.
But the scientific evidence that humour is beneficial to our general health is not very robust. This question is reviewed by Gil Greengros in
the Psychologist
recently and his paper is illuminating.
Norman Cousins (1915-1990) was a well-known US liberal political journalist and author. He developed a bad case of painful connective tissue disease plus ankylosing spondylitis with a very low probability (1/500) of recovery.
Cousins followed all conventional medical advice for the treatment of the disease but supplemented this with a novel treatment – he took large doses of vitamin C and indulged in self-induced bursts of laughter every day by watching comic films.
READ MORE
He told his story in his 1979 book Anatomy of an Illness as Perceived by the Patient. Actor Ed Asner starred in a 1984 TV film based on this book. Cousin's book launched a laughter/humour/therapy movement that is still with us today.
Norman Cousins recovered from his illness, but the account in his book is anecdotal, not a scientific study
In Anatomy of an Illness, Cousins claimed laughter had an analgesic effect on him: 'I made the joyous discovery that 10 minutes of genuine belly laughter had an anaesthetic effect that would give me at least two hours of painless sleep.'
Cousins recovered from his illness, but the account in his book is anecdotal, not a scientific study, and doesn't prove that humour/laughter played a significant part in effecting his cure. His acute arthritic condition may have just subsided slowly and naturally.
Greengros points out that scientific studies of the relationship between humour and general health have been plagued by problems such as small sample size and confounding variables, with the result that few firm conclusions can be drawn.
There is some evidence that your mood can boost the immune system, eg watching funny films boosts immunity and reduces allergic reactions compared to non-humorous controls. But this effect is not exclusive to humour and can also be induced by listening to classical music or by sad feelings.
Some people claim the physical activity involved in hearty laughter is itself a powerful aerobic exercise, producing health benefits
Do professional comedians live longer or have better general health than other professionals? Studies have shown that comedians and comedy writers die younger than actors and other professionals who aren't comic entertainers. But uncontrolled-for factors such as unhealthy lifestyle confound such studies.
Some people claim the physical activity involved in hearty laughter is itself a powerful aerobic exercise, producing health benefits. Claims have been made that several minutes of robust laughter is equivalent to the aerobic work of exercising 10-15 minutes on the rowing machine. However, careful studies have demonstrated that normal laughter is equivalent only to very light exercise, such as playing cards.
Indian doctor Modan Karice founded the first Yoga Laughter Club in 1995, where people come to laugh as much as possible, even in the absence of humorous stimulation, aiming to stimulate good health and induce happiness. Studies have failed to produce convincing evidence that this significantly promotes better physical/mental health
Possibly the best evidence for a therapeutic effect of humour on health is the capacity to reduce pain. Only genuine laughter is effective because only this emotional change releases the endorphins that relieve pain – deliberately exercising the muscular action of laughing alone doesn't work.
There is strong evidence that humour benefits mental health by lowering stress. The ability to make other people laugh is a very attractive trait
This analgesic effect is temporary. Cousins's laughter gave him two hours' relief, although he said that, if he then had another genuine bout of laughter, he got further relief. It should also be noted that other forms of neural stimulation, such as relaxing music or listening to lectures, have the same effect.
So, evidence to date that humour promotes general health is weak. On the other hand, there is strong evidence that humour benefits mental health by lowering stress. The ability to make other people laugh is a very attractive trait and laughter generally is very enjoyable. Greengros sensibly advises that we should all enjoy humour and welcome it as one of the good things in life.
Let me finish with a little joke to cheer you up and, perhaps, give you a little physical boost also. What did the Tibetan monk say when he saw the face of Jesus in a tub of margarine? 'I can't believe it's not Buddha'.
William Reville is an emeritus professor of Biochemistry at UCC
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


RTÉ News
3 hours ago
- RTÉ News
J&J to invest $2 billion to boost US manufacturing as drug tariffs loom
Johnson & Johnson said today it would invest $2 billion in North Carolina as it aims to expand its US manufacturing presence amid looming drug import duties proposed by President Donald Trump's administration. Major drugmakers, including Eli Lilly and AstraZeneca, have also committed to shell out billions of dollars to scale up their US footprint in response to Trump's efforts, including tariff threats. Earlier this month, Trump said he plans to impose phased-in tariffs for the pharmaceutical sector, which could start small and eventually rise to 250%. J&J said today it has reached a 10-year agreement with Tokyo-based contract drug developer Fujifilm Diosynth for its more than 160,000-square-foot manufacturing facility in Holly Springs, North Carolina, which would create about 120 new jobs. Fujifilm in April had signed a more than $3 billion deal with Regeneron to manufacture and supply drug products for the US-based company at its North Carolina facility for a span of 10 years. J&J would also announce plans for additional manufacturing facilities in the US and the expansion of current US sites in the coming months. The healthcare conglomerate had said in March it would raise US investments by 25% to more than $55 billion over the next four years, including a separate plant in Wilson, North Carolina.


Irish Times
a day ago
- Irish Times
Novo Nordisk freezes hiring in push to rein in costs
Novo Nordisk is to freeze hiring in an effort to control costs at the drug maker. The halt will apply across all markets and departments, with the exception of business-critical roles, a company spokeswoman said on Wednesday. Novo's new chief executive officer, Maziar Mike Doustdar, has signaled that job cuts may be part of a promised revamp, telling reporters last month that Novo needs to exercise greater discipline and prudence on spending. He said he plans to review the company's cost base. The maker of Wegovy and Ozempic, which employs close to 500 people in Ireland, is fighting to claw back ground after losing its lead in the US obesity market to rival Eli Lilly & Co. Lilly's weight-loss franchise is poised to overtake Novo's this year and may hold more than half of a $100 billion global obesity market by 2030, Bloomberg Intelligence analyst Michael Shah said. Novo ousted its longtime CEO in the second quarter as the foundation that controls the company pushed for an overhaul, and Doustdar took over earlier this month. Novo's workforce mushroomed to more than 78,000 people in recent years as the drugmaker rushed to boost production of its blockbusters Ozempic and Wegovy. On Wednesday, the company's website had just over 400 jobs posted globally, most of them in China and the U.S. Only eight positions were open in its home market of Denmark. --Bloomberg


The Irish Sun
6 days ago
- The Irish Sun
Your ultimate guide to beat the Mounjaro price hike – from switching jabs to getting them FREE on the NHS
From the differences between Mounjaro and Wegovy to cheating the postcode lottery, we reveal everything you need to know... as well as common jab mistakes stopping you losing weight JABS UP Your ultimate guide to beat the Mounjaro price hike – from switching jabs to getting them FREE on the NHS THE price of Mounjaro is set to soar, The Sun revealed yesterday - leaving slimmers desperate and worried at how they will afford the 'life-changing' drug. With the price hike looming on September 1, we reveal how to dodge the spiralling bills, getting your jabs for cheaper - or even free on the NHS - as well as the different side effects to be wary of. Advertisement 2 Eli Lilly has increased its prices of Mounjaro in the UK Credit: Getty The NHS has been giving Mounjaro prescriptions within GP practices since June. Private pharmacies boast 'no GP referral needed', with tantalising prices drawing in an estimated one million paying customers. Costs vary depending on the provider, jab and dosage, but are currently between around £120 and £220 per month. But that's all set to change, as the US-based maker of Mounjaro, Eli Lilly, told The Sun it will be increasing charges in Britain to 'address inconsistencies' with prices it commands from other western countries. Advertisement The price the pharma giant charges pharmacies for a mid-range 5mg dose will nearly double from £92 to £180 from September 1. The maximum available dose, 15mg, will rise from £122 to £330. Eli Lilly claimed to have negotiated with big private suppliers to ensure the whole price increase is not passed on to patients - but with pharmacies already marking up jab prices, the public can expect to see the cost increase. It marks a huge blow for those for whom the jab offers a life-saving way out of obesity. The hefty price would affect those currently on the jabs, as well as those who had hoped to pay for them long-term to avoid weight regain. Toby Nicol, CEO at CheqUp, which has around 50,000 customers on weight loss jabs, said: 'This news will be disappointing for those who have achieved life-changing results with Mounjaro. Advertisement 'This is particularly the case for those on higher doses who will likely see substantial rises in price." Weight Loss Jabs - Pros vs Cons Mounjaro has been dubbed the 'King Kong' of fat jabs because its success tops other brands, including Wegovy (also called Ozempic for type 2 diabetes), and Saxenda. Now, with people considering switching to Wegvoy, some providers appear to have hiked prices of the alternative jab that's similar to Ozempic, in response to the update. Mr Nicol, who says they have reduced the price of Wegovy on CheqUp, says: "Wegovy is a brilliant drug and that's why we don't want anyone to be priced out and think they have to take something which is unsafe. "Do not buy from the cowboys. If the price is to good to be true, it probably is." Advertisement There is no direct dose equivalent, so swapping between drugs is not possible Dr Suhail Hussain Dr Ralph Abraham, a diabetes and endocrinology specialist verified on Doctify, a healthcare review platform, says: 'There is no problem in switching from one drug to another. 'But in a world where the drugs are often not prescribed by experienced doctors, it then becomes difficult to know where side effects might lie.' Here, we answer the worries of readers and address how this could influence weight loss jabs and their success. CAN I SWITCH TO WEGOVY? IT depends who you ask. Mr Nicol says: "It's clinically acceptable to go from Mounjaro to Wegovy. We are developing our own switching plan. Advertisement 'While Mounjaro remains the most effective treatment available, Wegovy is a more affordable option and is also clinically proven as a highly effective weight loss drug that has delivered incredible results for people who are on a weight loss journey. 'We are ready and able to provide advice to those who are looking to switch.' But Dr Suhail Hussain, a private GP verified on Doctify, believes this is likely to affect weight loss. 'There is no direct dose equivalent, so swapping between drugs is not possible,' he says. Wegovy is prescribed between 0.25mg and 2.4mg, while Mounjaro has doses between 2.5mg and 15mg. Advertisement Dr Hussain said: 'The weight loss drugs are generally started at the lowest dose and titrated up. 'So if you were on mid-strength Mounjaro you would have to go onto the lowest strength Wegovy. 'There may also need to be a 'wash out' period to wean off one on to the other - which will again have impact on results." But Mr Nicol says: "It doesn't feel right to do that, it's like a game of snakes and ladders. "We'd be saying to people, for example, on 7.5mg of Mounjaro, that they shuold be transferring over to 1.7mg of Wegovy." Advertisement Patients should receive clinically appropriate care, under supervision, that aligns with their individual health needs and personal circumstances, experts said. WHAT ARE THE RISKS OF SWITCHING TO WEGOVY? A USER would also need to adjust to the side effects of a new medicine. While these are relatively the same for either jab, there are slight differences. 'Mounjaro tends to be better tolerated in terms of GI side effects than Weygovy, so you may experience more nausea or vomiting etc,' says Dr Hussain. The 'very common' side effects of both Mounjaro and Wegovy are nausea, diarrhoea, vomiting and constipation, according to Asda Online Doctor. Advertisement But Wegovy also says headache, stomach pain and feeling weak or tired are very common. WILL I LOSE AS MUCH WEIGHT ON WEGOVY? THE active ingredient in Wegovy is semaglutide, while in Mounjaro it is tirzepatide. Both work in a very similar way on the body. Dr Hussain says: 'The two drugs work in a similar way (both are GLP-1 receptor agonists) but have some important differences. 'Mounjaro is a dual GIP + GLP-1 receptor agonist, while Wegovy is GLP-1 agonist only. 'Therefore, there may be a difference in impact on appetite suppression and hence subsequent weight loss.' Advertisement Mounjaro is a Ferrari, Wegovy is a Porsche, and diet and exercise is a horse and cart. Toby Nicol GLP-1 is a natural hormone released in your gut when you eat. By activating GLP-1 receptors, Wegovy helps slow down stomach emptying and control blood sugar levels, helping with fullness and sending a message to the brain to reduce food intake. Mounjaro does this too, but also mimics the hormone GIP, which also plays a role in blood sugar regulation and appetite. It's dual-action may be why Mounjaro is the preferred jab of choice for weight loss. 2 Is your weight loss journey at risk of being halted? You have options, experts say Credit: Getty Advertisement How much does Mounjaro cost now? The price of Mounjaro doses: These are general prices, but they vary by provider within a £30 range. 2.5mg: £120 5mg: £140 7.5mg: £150 10mg: £170 12.5mg: £210 15mg: £210 Mounjaro can help you lose around 21 per cent of your body weight, while Wegovy can help you lose 14.9 per cent. In one trial of Mounjaro, the SURMOUNT-1 trial of tirzepatide in non-diabetic patients over 72 weeks, people lost up to 22.5 per cent of their body weight while taking the highest maintenance dose. More than 89 per cent of people lost at least five per cent of their starting weight. STEP-1, a 68-week clinical trial carried out to study the weight loss effects of semaglutide (Wegovy), found that people lost up to 17 per cent of their body weight after taking the 2.4mg maintenance dose. Up to 85 per cent of patients lost at least five per cent of their starting weight. Advertisement Mr Nicol said: "Mounjaro is a Ferrari, Wegovy is a Porsche, and diet and exercise is a horse and cart." HOW CAN I GET THE JAB CHEAPER? SWITCHING to Wegovy might save you money - if your provider hasn't increased its prices. Below is a box showing the price of the highest dose of Wegovy and Mounjaro - but because the doses are not comparable, it's difficult to also compare their prices. Eli Lilly claimed it is negotiating with providers so that the whole increase is not passed on to patients. Mr Nicol said: 'At CheqUp we are determined to support our patients as best we can – and can announce today that despite these price rises we will not raise prices for those who are on the two lowest doses of Mounjaro. Advertisement 'We will also not pass on the full cost of the price rise for those on higher doses.' PRICES OF MOUNJARO AND WEGOVY Below is a price comparison of Mounjaro and Wegovy at some of the UK's most popular providers. NOTE: SOME PROVIDERS CONSIDER THE HIGHEST DOSE A MAINTENANCE DOSE AT THE END OF TREATMENT, AND IT IS NOT IMPERATIVE TO REACH IT. DOSES ARE ALSO NOT COMPARABLE. Prices as of August 14, 2025 CheqUp Mounjaro (tirzepatide) highest dose: £209 Wegovy (semaglutide) highest dose: £160 ASDA Online Doctor Mounjaro (tirzepatide) highest dose: £204 Wegovy (semaglutide) highest dose: £188.98 Oxford Online Pharmacy Mounjaro (tirzepatide) highest dose: £198.97 Wegovy (semaglutide) highest dose: £248.99 MedExpress Mounjaro (tirzepatide) highest dose: £199.99 Wegovy (semaglutide) highest dose: £199.99 Superdrug Online Doctor Mounjaro (tirzepatide) highest dose: £245 Wegovy (semaglutide) highest dose: £295 HOW CAN I GET MOUNJARO FREE ON THE NHS? IT was a game-changing moment when the NHS announced it would be prescribing weight loss jabs for free. You need to fit a strict set of criteria to be eligible, but the initial rollout is extremely limited to just 22,000 patients over the next three years. There are 3.4million people in England who would qualify for treatment under the NICE eligibility criteria. The NHS says you'll only be prescribed semaglutide (Wegovy) if you have health problems due to your weight and you have a BMI of either: Advertisement 35 or more, or 32.5 or more if you're of Asian, Chinese, Middle Eastern, Black African or African-Caribbean origin 30 to 34.9, or 27.5 to 32.4 if you're of Asian, Chinese, Middle Eastern, Black African or African-Caribbean origin, and you meet other criteria to be treated by a specialist weight management service Only a specialist weight management service can prescribe semaglutide. You may be eligible for tirzepatide (Mounjaro) from a GP if you have: A BMI of 40 or more And have at least four of these weight-related health conditions: type 2 diabetes high blood pressure (hypertension) heart disease (cardiovascular disease) abnormal blood fats (dyslipidaemia) obstructive sleep apnoea A weight management service or GP can prescribe tirzepatite. CAN I GET AROUND THE POSTCODE LOTTERY? THERE is a 'postcode lottery' of prescription, so whether you can access the drugs depends largely on where you live. Advertisement Shockingly, as little as eight out of 42 NHS Integrated Health Boards are prescribing the jabs, according to Sky News. Can you get around it? 'No,' says Dr Hussain. The NHS says you can check with your local Integrated Care Board to see if you are eligible for an assessment. Some GP practices have begged patients to stop requesting it from them. For example, a statement from Dr Khan's Practice in Clayton, Manchester, read: 'Tirzepatide (Mounjaro) is not currently available anywhere in Greater Manchester, including GP practices, hospitals or specialist weight management services. Advertisement 'Please do not contact us to request it – you'll be contacted directly if you are eligible when the service becomes available in the area. 'Dr Khans Practice are not prescribing GLP-1 medications for weight loss until a service agreement is in place with Manchester ICB which is currently under review.'